Article info
PDFOriginal research
Allocation of scarce biospecimens for use in research
- Correspondence to Leah Pierson, MD-PhD Program, Harvard Medical School, Boston, MA 02115, USA; leah_pierson{at}hms.harvard.edu
Citation
Allocation of scarce biospecimens for use in research
Publication history
- Received August 13, 2019
- Revised January 23, 2020
- Accepted February 24, 2020
- First published March 27, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Practice evaluation of biobank ethics and governance: current needs and future perspectives
- Grants and Contracts, JIM 61-2
- International requirements for consent in biobank research: qualitative review of research guidelines
- Biobank research, informed consent and society. Towards a new alliance?
- Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents
- NIDDK CENTERS FOR DIABETES TRANSLATION RESEARCH (P30): RFA-DK-15-003
- Community organisation-researcher partnerships: what concerns arise for community organisations and how can they be mitigated?
- EARLY-STAGE INNOVATIVE TECHNOLOGY DEVELOPMENT FOR CANCER RESEARCH (R21): RFA-CA-12-002
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile